Lente insulin: Difference between revisions
Content deleted Content added
Berchanhimez (talk | contribs) ultralente has a stub article, I'm making a stub for lente in the hopes that COVID is going to give me some time to add to both of these historically important insulins. Tag: Removed redirect |
|||
| Line 1: | Line 1: | ||
'''Lente insulin''' was an intermediate duration [[insulin]] that is no longer used in humans.<ref>{{cite news |last1=Holmberg |first1=Monica |title=An Overview of Insulin Breakthroughs |url=https://www.pharmacytimes.com/publications/issue/2006/2006-10/2006-10-5917 |accessdate=11 May 2020 |work=Pharmacy Times |volume=2006 |issue=10 |publisher=Pharmacy & Healthcare Communications |date=1 October 2006}}</ref> The onset of lente insulin is 1-2 hours after the dose is administered, and the effects can last up to 8-12 hours. <ref>{{cite journal |last1=Owens |first1=David R. |title=Insulin Preparations with Prolonged Effect |journal=Diabetes Technology & Therapeutics |date=June 2011 |volume=13 |issue=S1 |pages=S-5–S-14 |doi=10.1089/dia.2011.0068}}</ref> Lente insulin, along with other insulin analogs in the same family, was discontinued by it's manufacturer, [[Eli Lilly and Company]], in the mid 2000s. This was in part because many doctors began to favor more predictable forms of insulin such as [[NPH insulin]].<ref>{{webarchive|url=http://web.archive.org/web/20111201191644/http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/ucm086084.pdf|date=1 December 2011|title=Discontinuation of Humulin®U ULTRALENTE}}</ref> |
|||
#redirect [[Glossary of diabetes#L]] |
|||
== References == |
|||
{{Reflist}} |
|||
{{Drug-stub}} |
|||
{{Oral hypoglycemics and insulin analogs}} |
|||
[[Category:Insulin therapies]] |
|||
Revision as of 01:18, 11 May 2020
Lente insulin was an intermediate duration insulin that is no longer used in humans.[1] The onset of lente insulin is 1-2 hours after the dose is administered, and the effects can last up to 8-12 hours. [2] Lente insulin, along with other insulin analogs in the same family, was discontinued by it's manufacturer, Eli Lilly and Company, in the mid 2000s. This was in part because many doctors began to favor more predictable forms of insulin such as NPH insulin.[3]
References
- ^ Holmberg, Monica (1 October 2006). "An Overview of Insulin Breakthroughs". Pharmacy Times. Vol. 2006, no. 10. Pharmacy & Healthcare Communications. Retrieved 11 May 2020.
- ^ Owens, David R. (June 2011). "Insulin Preparations with Prolonged Effect". Diabetes Technology & Therapeutics. 13 (S1): S-5–S-14. doi:10.1089/dia.2011.0068.
- ^ Discontinuation of Humulin®U ULTRALENTE at the Wayback Machine (archived 1 December 2011)
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |